Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

144 7 Immunosuppresive Factors in Cancer
Interleukin-10 down-regulates MHC
class II ab peptide complexes at the
plasma membrane of monocytes by affecting
arrival and recycling. Immunity
7: 861.
131 Ding, L., P. S. Linsley, L. Y. Huang,
R. N. Germain and E. M. Shevach.
1993. IL-10 inhibits macrophage costimulatory
activity by selectively inhibiting
the up-regulation of B7 expression.
J. Immunol. 151: 1224.
132 Willems, F., A. Marchant, J. P. Delville,
C. Gerard, A. Delvaux, T. Velu,
M. de Boer and M. Goldman. 1994.
Interleukin-10 inhibits B7 and intercellular
adhesion molecule-1 expression
on human monocytes. Eur. J. Immunol.
24: 1007.
133 Walker, T. M., C. J. Burger and
K. D. Elgert. 1994. Tumor growth alters
T cell and macrophage production
of and responsiveness to granulocytemacrophage
colony-stimulating factor:
partial dysregulation through interleukin-10.
Cell Immunol. 154: 342.
134 de Waal Malefyt, R., H. Yssel and
J. E. de Vries. 1993. Direct effects of IL-
10 on subsets of human CD4 + T cell
clones and resting T cells. Specific inhibition
of IL-2 production and proliferation.
J. Immunol. 150: 4754.
135 Taga, K. and G. Tosato. 1992. IL-10 inhibits
human T cell proliferation and
IL-2 production. J. Immunol. 148: 1143.
136 Barth, R. J., Jr, M. A. Coppola and
W. R. Green. 1996. In vivo effects of locally
secreted IL-10 on the murine antitumor
immune response. Ann. Surg.
Oncol. 3: 381.
137 Steinbrink, K., H. Jonuleit, G. Muller,
G. Schuler, J. Knop and A. H. Enk.
1999. Interleukin-10-treated human
dendritic cells induce a melanoma-antigen-specific
anergy in CD8(+) T cells resulting
in a failure to lyse tumor cells.
Blood 93: 1634.
138 Steinbrink, K., M. Wolfl, H. Jonuleit,
J. Knop and A. H. Enk. 1997. Induction
of tolerance by IL-10-treated
dendritic cells. J. Immunol. 159: 4772.
139 Groux, H., M. Bigler, J. E. de Vries
and M. G. Roncarolo. 1996. Interleukin-10
induces a long-term antigen-spe-
cific anergic state in human CD4 + T
cells. J. Exp. Med. 184: 19.
140 Chen, M. L., F. H. Wang, P. K. Lee
and C. M. Lin. 2001. Interleukin-10-induced
T cell unresponsiveness can be
reversed by dendritic cell stimulation.
Immunol. Lett. 75: 91.
141 Bejarano, M. T., R. de Waal Malefyt,
J. S. Abrams, M. Bigler, R. Bacchetta,
J. E. de Vries and M. G. Roncarolo.
1992. Interleukin 10 inhibits allogeneic
proliferative and cytotoxic T cell responses
generated in primary mixed
lymphocyte cultures. Int. Immunol. 4:
1389.
142 Hsieh, C. L., D. S. Chen and
L. H. Hwang. 2000. Tumor-induced immunosuppression:
a barrier to immunotherapy
of large tumors by cytokinesecreting
tumor vaccine. Hum. Gene
Ther. 11: 681.
143 Fitzpatrick, L., A. P. Makrigiannis,
M. Kaiser and D. W. Hoskin. 1996.
Anti-CD3-activated killer T cells: interferon-g
and interleukin-10 cross-regulate
granzyme B expression and the induction
of major histocompatibility
complex-unrestricted cytotoxicity. J. Interferon
Cytokine Res. 16: 537.
144 Wang, L., E. Goillot and R. I. Tepper.
1994. IL-10 inhibits alloreactive cytotoxic
T lymphocyte generation in vivo.
Cell. Immunol. 159: 152.
145 Sharma, S., M. Stolina,Y. Lin,
B. Gardner, P. W. Miller, M. Kronenberg
and S. M. Dubinett. 1999. T cellderived
IL-10 promotes lung cancer
growth by suppressing both T cell and
APC function. J. Immunol. 163: 5020.
146 Huang, S., S. E. Ullrich and M. Bar-
Eli. 1999. Regulation of tumor growth
and metastasis by interleukin-10: the
melanoma experience. J. Interferon Cytokine
Res. 19: 697.
147 Zheng, L. M., D. M. Ojcius, F. Garaud,
C. Roth, E. Maxwell, Z. Li,
H. Rong, J. Chen, X. Y. Wang, J. J. Catino
and I. King. 1996. Interleukin-10
inhibits tumor metastasis through an
NK cell-dependent mechanism. J. Exp.
Med. 184: 579.
148 Jinquan, T., C. G. Larsen, B. Gesser,
K. Matsushima and K. Thestrup-Pedersen.
1993. Human IL-10 is a che-